[go: up one dir, main page]

ES356078A1 - Method of Manufacture of Complex Compounds of Ferric Iron with Hydrogenated Dextran and of Complex Compounds of Ferric Iron with Hydrogenated Dextran and Sodium Citrate or Citric Acid. - Google Patents

Method of Manufacture of Complex Compounds of Ferric Iron with Hydrogenated Dextran and of Complex Compounds of Ferric Iron with Hydrogenated Dextran and Sodium Citrate or Citric Acid.

Info

Publication number
ES356078A1
ES356078A1 ES356078A ES356078A ES356078A1 ES 356078 A1 ES356078 A1 ES 356078A1 ES 356078 A ES356078 A ES 356078A ES 356078 A ES356078 A ES 356078A ES 356078 A1 ES356078 A1 ES 356078A1
Authority
ES
Spain
Prior art keywords
complex compounds
ferric iron
hydrogenated dextran
manufacture
citric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES356078A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kutnowskie Zaklady Farmaceutyczne Polfa SA
Original Assignee
Kutnowskie Zaklady Farmaceutyczne Polfa SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PL121667A external-priority patent/PL58638B1/pl
Application filed by Kutnowskie Zaklady Farmaceutyczne Polfa SA filed Critical Kutnowskie Zaklady Farmaceutyczne Polfa SA
Publication of ES356078A1 publication Critical patent/ES356078A1/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A deionized complex of FeOH 3 with hydrogenated dextram, prepared by reaction of FeOH 3 with the dextram under alkaline conditions (see Division C3), is used as a solution in aqueous NaCl as an injection solution in the treatment of inon-definciency diseases
ES356078A 1967-07-13 1968-07-12 Method of Manufacture of Complex Compounds of Ferric Iron with Hydrogenated Dextran and of Complex Compounds of Ferric Iron with Hydrogenated Dextran and Sodium Citrate or Citric Acid. Expired ES356078A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL121667A PL58638B1 (en) 1967-07-13
PL121668A PL58639B1 (en) 1967-07-13

Publications (1)

Publication Number Publication Date
ES356078A1 true ES356078A1 (en) 1970-03-16

Family

ID=26652814

Family Applications (1)

Application Number Title Priority Date Filing Date
ES356078A Expired ES356078A1 (en) 1967-07-13 1968-07-12 Method of Manufacture of Complex Compounds of Ferric Iron with Hydrogenated Dextran and of Complex Compounds of Ferric Iron with Hydrogenated Dextran and Sodium Citrate or Citric Acid.

Country Status (6)

Country Link
CH (1) CH507993A (en)
DE (1) DE1768912A1 (en)
DK (1) DK122398B (en)
ES (1) ES356078A1 (en)
GB (1) GB1196855A (en)
SE (1) SE344950B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK172860B1 (en) 1998-03-25 1999-08-16 Pharmacosmos Holding As Iron dextran compound for use as a component of a therapeutic agent for the prevention or treatment of iron man

Also Published As

Publication number Publication date
SE344950B (en) 1972-05-08
DE1768912A1 (en) 1972-05-10
CH507993A (en) 1971-05-31
GB1196855A (en) 1970-07-01
DK122398B (en) 1972-02-28

Similar Documents

Publication Publication Date Title
ES397611A1 (en) Zirconium rinse for phosphate coated metal surfaces
CU20626L (en) FERRIC HYDROXIDE THERAPEUTIC COMPLEXES AND PREPARATION PROCEDURE
ES356078A1 (en) Method of Manufacture of Complex Compounds of Ferric Iron with Hydrogenated Dextran and of Complex Compounds of Ferric Iron with Hydrogenated Dextran and Sodium Citrate or Citric Acid.
ES8100263A1 (en) PROCEDURE TO PREPARE A 1-BENZL-1,2,5,6-TETRAHYDROPYRIDINE-3-CARBOXYL ACID DERIVATIVE
ES409333A1 (en) Stabilization of aqueous solutions of bromine
ES326448A1 (en) PROCEDURE FOR OBTAINING A THERAPEUTIC COMPOSITION OF MUCOLITIC ACTION.
ES348122A1 (en) Process for the manufacture of 4,4'-diamino-1,1'-dianthraquinonylenes
ES399409A1 (en) Ether carboxylic acids
GB1202120A (en) A method of preparing comenic acid
GB901624A (en) Depilatory paste composition
BE755067A (en) AQUEOUS POLYMERISATE DISPERSIONS, CONTAINING P-AMINOBENZOIC ACID DERIVATIVES
GB1397189A (en) Acid-modified polyterephthalic acid esters
ES416766A1 (en) A procedure for the preparation of (3-trifluormethylphenoxy) - (4-chlorophenyl) acetate of 2-acetamidoetilo. (Machine-translation by Google Translate, not legally binding)
ES294928A1 (en) A procedure to prepare a liquid and stable composition of tetracycline (Machine-translation by Google Translate, not legally binding)
ES407523A1 (en) Natiinflammatory agents
FR2426698A2 (en) Sodium salt of naringin prepn. - from naringin and sodium hydroxide in alcohol, used for treating circulatory and ophthalmic disorders
GB1045969A (en) Sodium betaine aspartate
ES385474A1 (en) Procedure for the preparation of alpha-escina by isomerization of beta-escina in aqueous solution. (Machine-translation by Google Translate, not legally binding)
GB1369409A (en) Process for the manufacture of 1-nitro-anthraquinone
ES388016A1 (en) A method of preparation of trans isomers of 1,2,3,4 cyclopentane-tetracarboxylic acids
ES349245A1 (en) Procedure for the obtaining of tetra-alkhiltiuram disulfures. (Machine-translation by Google Translate, not legally binding)
ES268270A3 (en) Process to improve the stability of ethinenobisdiycarbamate of cinc (Machine-translation by Google Translate, not legally binding)
JPS51123902A (en) Plunger pump
GB555314A (en) 4,4-derivatives of 2-carboxydiphenylsulphones and esters
ES231829A1 (en) A procedure for the preparation of a nitrophurazone concentrate (Machine-translation by Google Translate, not legally binding)